Wesana Health Holdings Inc. (WSNAF)
| Previous Close | 2.1000 |
| Open | 2.0674 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.9600 - 2.1000 |
| 52 Week Range | 1.8600 - 3.9970 |
| Volume | 53,550 |
| Avg. Volume | 38,805 |
| Market Cap | 26.108M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2820 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing
Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.
- CNW Group
KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference. Individual investors, institutional investors, advisors, and analysts are invited to attend the two-day program beginning Wednesday, October 13, 2021, at 9:45 a.m. ET.
- GlobeNewswire
Wesana Health Announces Inclusion in the AdvisorShares Psychedelics ETF
CHICAGO and TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including through the advancement of psychedelic medicines, is pleased to announce its inclusion in the AdvisorShares Psychedelics ETF (the “Fund”), currently trading under the ticker
